Active Ingredient History

  • Now
Mirogabalin is a medication developed by Daiichi Sankyo, a gabapentinoid. Gabapentin and pregabalin are also members of this class. As a gabapentinoid, mirogabalin binds to the α2δ subunit of voltage-gated calcium channel, but with significantly higher potency than pregabalin. It has shown promising results in Phase II clinical trials for the treatment of diabetic peripheral neuropathic pain.   Wikipedia

  • SMILES: CCC1=C[C@@H]2[C@H](C1)C[C@]2(CN)CC(=O)O
  • Mol. Mass: 209.29
  • ALogP: 1.78
  • ChEMBL Molecule:
More Chemistry
aminomethyl)-3-ethyl-bicyclo(3.2.0)hept-3-ene-6-acetic acid | ds-5565 | mirogabalin


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue